HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hexamethylmelamine (NSC-13875) alone and in combination with 5-(3, 3-dimethyl-1-triazeno) imidazole-4-carboxamide (NSC-45388) in the treatment of advanced cancer.

AuthorsD C Stolinsky, D L Bogdon, J Solomon, J R Bateman
JournalCancer (Cancer) Vol. 30 Issue 3 Pg. 654-9 (Sep 1972) ISSN: 0008-543X [Print] United States
PMID5075351 (Publication Type: Journal Article)
Chemical References
  • Amides
  • Antineoplastic Agents
  • Chemosterilants
  • Dimethylamines
  • Imidazoles
  • Triazenes
  • Triazines
Topics
  • Administration, Oral
  • Amides (adverse effects, therapeutic use)
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Carcinoma, Squamous Cell (drug therapy)
  • Chemosterilants (adverse effects, therapeutic use)
  • Dimethylamines (adverse effects, therapeutic use)
  • Female
  • Humans
  • Imidazoles (adverse effects, therapeutic use)
  • Leukopenia (chemically induced)
  • Lung Neoplasms (drug therapy)
  • Male
  • Melanoma (drug therapy)
  • Nausea (chemically induced)
  • Neoplasms (drug therapy)
  • Neurologic Manifestations
  • Thrombocytopenia (chemically induced)
  • Triazenes (adverse effects, therapeutic use)
  • Triazines (adverse effects, therapeutic use)
  • Uterine Cervical Neoplasms (drug therapy)
  • Vomiting (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: